ShanghaiTech University Knowledge Management System
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. | |
xiexiong1,2; Qiaoshuai Lan3; Jinyi Zhao2,4; Sulin Zhang1,2; Liu L(刘露)1,2,4; Yumin Zhang5; Wei Xu3; Maolin Shao2,4; Jingjing Peng1,2; Shuai Xia3; Yan Zhu4; Keke Zhang1,6; Xianglei Zhang4; Ruxue Zhang2,5; Jian Li1,6; Wenhao Dai1,2; Zhen Ge6; Shulei Hu1; Changyue Yu1,2; Jiang Wang1,2; Dakota Ma1; Mingyue Zheng1,2,6,7; Haitao Yang4; Gengfu Xiao2,5; Zihe Rao4; Lu Lu3; Leike Zhang2,5; Fang Bai4; Yao Zhao8; Shibo Jiang3; Hong Liu1,2,4,6,7
| |
2024-03-06 | |
发表期刊 | SIGNAL TRANSDUCTION AND TARGETED THERAPY |
ISSN | 2095-9907 |
EISSN | 2059-3635 |
卷号 | 9页码:1651-1664 |
发表状态 | 已发表 |
DOI | 10.1038/s41392-024-01758-8 |
摘要 | Respiratory disease caused by coronavirus infection remains a global health crisis. Although several SARS-CoV-2-specific vaccines and direct-acting antivirals are available, their efficacy on emerging coronaviruses in the future, including SARS-CoV-2 variants, might be compromised. Host-targeting antivirals provide preventive and therapeutic strategies to overcome resistance and manage future outbreak of emerging coronaviruses. Cathepsin L (CTSL) and calpain-1 (CAPN1) are host cysteine proteases which play crucial roles in coronaviral entrance into cells and infection-related immune response. Here, two peptidomimetic α-ketoamide compounds, 14a and 14b, were identified as potent dual target inhibitors against CTSL and CAPN1. The X-ray crystal structures of human CTSL and CAPN1 in complex with 14a and 14b revealed the covalent binding of α-ketoamide groups of 14a and 14b to C25 of CTSL and C115 of CAPN1. Both showed potent and broad-spectrum anticoronaviral activities in vitro, and it is worth noting that they exhibited low nanomolar potency against SARS-CoV-2 and its variants of concern (VOCs) with EC50 values ranging from 0.80 to 161.7 nM in various cells. Preliminary mechanistic exploration indicated that they exhibited anticoronaviral activity through blocking viral entrance. Moreover, 14a and 14b exhibited good oral pharmacokinetic properties in mice, rats and dogs, and favorable safety in mice. In addition, both 14a and 14b treatments demonstrated potent antiviral potency against SARS-CoV-2 XBB 1.16 variant infection in a K18-hACE2 transgenic mouse model. And 14b also showed effective antiviral activity against HCoV-OC43 infection in a mouse model with a final survival rate of 60%. Further evaluation showed that 14a and 14b exhibited excellent anti-inflammatory effects in Raw 264.7 mouse macrophages and in mice with acute pneumonia. Taken together, these results suggested that 14a and 14b are promising drug candidates, providing novel insight into developing pan-coronavirus inhibitors with antiviral and anti-inflammatory properties. |
学科门类 | 理学 ; 理学::生物学 ; 医学 ; 医学::药学(可授医学、理学学位) |
URL | 查看原文 |
收录类别 | SCI |
语种 | 英语 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/452308 |
专题 | 免疫化学研究所 免疫化学研究所_特聘教授组_饶子和组 生命科学与技术学院_特聘教授组_柳红组 生命科学与技术学院_硕士生 生命科学与技术学院_博士生 免疫化学研究所_PI研究组_杨海涛组 免疫化学研究所_PI研究组_白芳组 |
共同第一作者 | Qiaoshuai Lan; Jinyi Zhao; Sulin Zhang; Liu L(刘露); Yumin Zhang; Wei Xu; Maolin Shao |
通讯作者 | Leike Zhang; Fang Bai; Yao Zhao; Shibo Jiang; Hong Liu |
作者单位 | 1.Drug Discovery and Design Center, State Key Laboratory of Drug Research, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences 2.University of Chinese Academy of Sciences 3.Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University 4.Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University 5.State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences 6.School of Chinese Materia Medica, Nanjing University of Chinese Medicine 7.School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS 8.National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital |
通讯作者单位 | 免疫化学研究所 |
推荐引用方式 GB/T 7714 | xiexiong,Qiaoshuai Lan,Jinyi Zhao,et al. Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1.[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2024,9:1651-1664. |
APA | xiexiong.,Qiaoshuai Lan.,Jinyi Zhao.,Sulin Zhang.,Liu L.,...&Hong Liu.(2024).Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1..SIGNAL TRANSDUCTION AND TARGETED THERAPY,9,1651-1664. |
MLA | xiexiong,et al."Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1.".SIGNAL TRANSDUCTION AND TARGETED THERAPY 9(2024):1651-1664. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。